Trial intelligence / Profile preview

Melatonin and Propranolol for Pediatric Migraine Prevention

NCT07743255Enrolling by invitation

Sponsor
Nishtar Medical University
Start
Jun 2026
Primary completion
Dec 2026
Countries
1
01

Overview

Randomised trial of melatonin in migraine (2 arms), sponsored by Nishtar Medical University. Primary endpoints: Change in Monthly Migraine Attack Frequency at 3 months and Change in Migraine Pain Severity at 3 months. Started Jun 2026; status: enrolling by invitation.

02

Drugs

melatonin
03

Conditions

migraine

Beyond the preview

Go deeper on NCT07743255.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07743255.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call